Senior insider sale
Chief Commercial Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$17.16M
274.91K shares
What this filing means
HEERMA PETER plans to sell 274.91K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $17.16M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/16/2026ACC: 0001950047-26-009576
Officer· Chief Commercial Officer
Since Oct 2019
274.91K
Shares to sell
$17.16M
Approx. market value
172.72K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/16/2026
172.72KTotal acquired172.72K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/16/2026 | Exercise of Stock Options Cash | 172.72K | — |
| Total | 172.72K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
102.19K
Market value
$6.36M
9/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
172.72K
Market value
$10.80M
9/16/2026
Total
Units
274.91K
Value
$17.16M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/15/2026 | 102.19K | $6.36M | — | Completed |
| Planned — Approximate Date | ||||
9/16/2026 | 172.72K | $10.80M | NASDAQ | Planned |
| Total | 274.91K | $17.16M | ||